LEXINGTON, Mass., June 21, 2021 /PRNewswire/ -- iSpecimen Inc.
(Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online
marketplace for human biospecimens, today announced the closing of
its previously announced initial public offering of 2,250,000
shares of its common stock at a price of $8.00 per share, for gross proceeds of
$18,000,000 before deducting
underwriting discounts, commissions and offering expenses. The
shares of common stock began trading on the Nasdaq Capital Market
under the ticker symbol "ISPC" on June 17,
ThinkEquity, a division of Fordham Financial Management, Inc.,
acted as the sole book-running manager for the offering.
A registration statement relating to this offering was declared
effective by the Securities and Exchange Commission ("SEC") on
June 16, 2021. A final prospectus
related to the offering was filed and is available on the SEC's
website at www.sec.gov. The offering was made only by means of a
prospectus. Electronic copies of the final prospectus may be
obtained from ThinkEquity, a division of Fordham Financial
Management, Inc., 17 State Street, 22nd Floor,
New York, New York 10004, by
telephone at (877) 436-3673 and by email at
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy these securities, nor shall there
be any sale of these securities in any state or jurisdiction in
which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state or jurisdiction.
iSpecimen offers an online marketplace
for human biospecimens, connecting life scientists in commercial
and non-profit organizations with healthcare providers that have
access to patients and specimens needed for medical discovery.
Proprietary, cloud-based technology enables scientists to
intuitively search for specimens and patients across a federated
partner network of hospitals, labs, biobanks, blood centers, and
other healthcare organizations. For more information about
iSpecimen, please visit www.ispecimen.com.
Forward Looking Statements
This press release contains
statements that constitute "forward-looking statements," including
with respect to the initial public offering and the anticipated use
of the net proceeds. No assurance can be given that the net
proceeds of the offering will be used as indicated. Forward-looking
statements are subject to numerous conditions, many of which are
beyond the control of the Company, including those set forth in the
Risk Factors section of the Company's registration statement and
final prospectus for the Company's offering filed with the SEC.
Copies of these documents are available on the SEC's website at
www.sec.gov. The Company undertakes no obligation to update these
statements for revisions or changes after the date of this release,
except as required by law.